The 4-T study of intensified insulin regimens shows excellent three-year glucose control with low risk of hypoglycaemia in type 2 diabetes

A long-awaited study presented today at the International Diabetes Federation World Diabetes Congress in Montreal, Canada, has shown that it is possible for patients with type 2 diabetes to achieve good blood glucose control with a very low rate of major hypoglycaemia even as they intensify their insulin treatment. The results of the ‘Treating to Target in Type 2 Diabetes’ (4-T) study that compared three different insulin treatment regimens over three years were also published online today by the New England Journal of Medicine.